RETRACTION: E.M. Abed, F. Yazdian, A.A. Sepahi, and B. Rasekh, “Synthesis and Evaluation of PCL/Chitosan/CQD-Fe Magnetic Nanocomposite for Wound Healing: Emphasis on Gene Expression,” Engineering in Life Sciences 25, no. 1 (2025): e202400038, https://doi.org/10.1002/elsc.202400038.
The above article, published online on 19 January 2025 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Ralf Takors; and Wiley-VCH GmbH. Following an investigation by the publisher, the parties have concluded that this article was accepted solely on the basis of a compromised peer review process. Therefore, the article must be retracted.
{"title":"RETRACTION: Synthesis and Evaluation of PCL/Chitosan/CQD-Fe Magnetic Nanocomposite for Wound Healing: Emphasis on Gene Expression","authors":"","doi":"10.1002/elsc.70040","DOIUrl":"10.1002/elsc.70040","url":null,"abstract":"<p><b>RETRACTION:</b> E.M. Abed, F. Yazdian, A.A. Sepahi, and B. Rasekh, “Synthesis and Evaluation of PCL/Chitosan/CQD-Fe Magnetic Nanocomposite for Wound Healing: Emphasis on Gene Expression,” <i>Engineering in Life Sciences</i> 25, no. 1 (2025): e202400038, https://doi.org/10.1002/elsc.202400038.</p><p>The above article, published online on 19 January 2025 in Wiley Online Library (http://onlinelibrary.wiley.com/), has been retracted by agreement between the journal Editor-in-Chief, Ralf Takors; and Wiley-VCH GmbH. Following an investigation by the publisher, the parties have concluded that this article was accepted solely on the basis of a compromised peer review process. Therefore, the article must be retracted.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"25 8","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/elsc.70040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Celosia argentea is an undervalued crop that shows potential for production enhancement due to elevated leaf nutrient accumulative ability. By investigating propagation using various in vitro culture systems, thidiazuron (TDZ)-supplemented nutrient media enhanced yield from 10 plants per explant in semi-solid medium, to 27 under continuous immersion in liquid media in recipient for automated temporary immersion (RITA) bioreactors, to 63 under temporary immersion in liquid media in a balloon-type bubble bioreactor (BTBB). TDZ in the BTBB system also increased shoot biomass and subsequent nutrient content relative to TDZ-free media in ex vitro plants. Ex vitro plants originating from both continuous and temporary media immersion in BTBBs outperformed those in all other culture systems in accumulating leaf Mg, Fe, Ca and Zn to meet the recommended dietary allowance for males and females. The genotypic variance and genetic advance of the mean at 5% selection intensity varied for each nutrient per culture system, with and without TDZ. Selective breeding at 5% selection intensity would improve leaf nutrient content but is specific to the culture system and the presence of TDZ. This is the first study to use liquid-based bioreactor systems for C. argentea propagation thereby providing new opportunities to upscale plant production for high nutrient-accumulating genotypes.
Practical application: This study establishes a commercially viable protocol for the large-scale clonal propagation of Celosia argentea, a nutrient-rich, fast growing leafy vegetable with untapped agronomic value. Using temporary immersion bioreactors and thidiazuron-supplemented media, the system delivers up to 63 plants per explant, more than 6-fold the yield of conventional methods, while significantly boosting leaf biomass and nutrient content (Mg, Ca, Fe, Zn). These results position C. argentea as a functional crop for health-focused markets and ready-to-cook vegetable lines. The low-input cultivation needs and rapid production cycle (8 weeks in vitro, 8 weeks ex vitro) make it ideal for high-turnover commercial nurseries, contract growers, and vertical farming operations. The systems reproducibility and high heritability of nutritional traits further support selective breeding programs for premium-value cultivars. This propagation platform offers agribusinesses a scalable entry point into the expanding market for nutrient-dense indigenous vegetables with health and wellness appeal.
阿根廷芹是一种被低估的作物,由于叶片养分积累能力的提高,显示出产量增加的潜力。通过研究不同体外培养体系的繁殖情况,在半固体培养基中,thidiazuron (TDZ)添加的营养培养基可使每个外植体的产量从10株增加到27株,在自动临时浸泡(RITA)生物反应器中,连续浸泡在液体培养基中,在气球型气泡生物反应器(BTBB)中,暂时浸泡在液体培养基中,每个外植体的产量增加到63株。与不含TDZ的培养基相比,BTBB体系中的TDZ也增加了离体植株的茎部生物量和随后的养分含量。在btbs中连续和暂时浸泡培养基的离体植株在积累叶片Mg、Fe、Ca和Zn方面都优于所有其他培养体系的离体植株,以满足雄性和雌性的推荐膳食摄入量。在有TDZ和没有TDZ的情况下,每个培养体系中每种养分在5%选择强度下的平均基因型变异和遗传进步是不同的。5%选择强度的选育可以提高叶片养分含量,但对培养体系和TDZ的存在有一定的影响。这是第一个使用液体生物反应器系统进行银青茶繁殖的研究,从而为高营养积累基因型的高端植物生产提供了新的机会。实际应用:本研究建立了一套商业上可行的大规模无性系繁殖方案,这是一种营养丰富、生长迅速、农艺价值尚未开发的叶类蔬菜。该系统使用临时浸泡生物反应器和补硫培养基,每个外植体最多可种植63株植物,产量是传统方法的6倍以上,同时显著提高叶片生物量和营养成分(Mg, Ca, Fe, Zn)。这些结果表明,银青茶是一种功能性作物,可用于注重健康的市场和即食蔬菜生产线。低投入的栽培需求和快速的生产周期(体外培养8周,体外培养8周)使其成为高周转率商业苗圃、合同种植者和垂直农业经营的理想选择。系统的可重复性和营养性状的高遗传力进一步支持了优质品种的选择育种计划。这个传播平台为农业企业提供了一个可扩展的切入点,进入营养丰富、具有健康和保健吸引力的本土蔬菜市场。
{"title":"Bioreactor Systems to Mass-Produce the Undervalued Crop, Celosia argentea, With High Nutrient Impact","authors":"Chandika Ramlall, Nisha Singh, Shakira Shaik","doi":"10.1002/elsc.70038","DOIUrl":"10.1002/elsc.70038","url":null,"abstract":"<p><i>Celosia argentea</i> is an undervalued crop that shows potential for production enhancement due to elevated leaf nutrient accumulative ability. By investigating propagation using various in vitro culture systems, thidiazuron (TDZ)-supplemented nutrient media enhanced yield from 10 plants per explant in semi-solid medium, to 27 under continuous immersion in liquid media in recipient for automated temporary immersion (RITA) bioreactors, to 63 under temporary immersion in liquid media in a balloon-type bubble bioreactor (BTBB). TDZ in the BTBB system also increased shoot biomass and subsequent nutrient content relative to TDZ-free media in ex vitro plants. Ex vitro plants originating from both continuous and temporary media immersion in BTBBs outperformed those in all other culture systems in accumulating leaf Mg, Fe, Ca and Zn to meet the recommended dietary allowance for males and females. The genotypic variance and genetic advance of the mean at 5% selection intensity varied for each nutrient per culture system, with and without TDZ. Selective breeding at 5% selection intensity would improve leaf nutrient content but is specific to the culture system and the presence of TDZ. This is the first study to use liquid-based bioreactor systems for <i>C. argentea</i> propagation thereby providing new opportunities to upscale plant production for high nutrient-accumulating genotypes.</p><p><i>Practical application</i>: This study establishes a commercially viable protocol for the large-scale clonal propagation of <i>Celosia argentea</i>, a nutrient-rich, fast growing leafy vegetable with untapped agronomic value. Using temporary immersion bioreactors and thidiazuron-supplemented media, the system delivers up to 63 plants per explant, more than 6-fold the yield of conventional methods, while significantly boosting leaf biomass and nutrient content (Mg, Ca, Fe, Zn). These results position <i>C. argentea</i> as a functional crop for health-focused markets and ready-to-cook vegetable lines. The low-input cultivation needs and rapid production cycle (8 weeks in vitro, 8 weeks ex vitro) make it ideal for high-turnover commercial nurseries, contract growers, and vertical farming operations. The systems reproducibility and high heritability of nutritional traits further support selective breeding programs for premium-value cultivars. This propagation platform offers agribusinesses a scalable entry point into the expanding market for nutrient-dense indigenous vegetables with health and wellness appeal.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"25 8","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/elsc.70038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RETRACTION: E. Rahmani, M. Pourmadadi, S. A. Ghorbanian, F. Yazdian, H. Rashedi, and M. Navaee, “Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy,” Engineering in Life Sciences 22, no. 10 (2022): 634–649, https://doi.org/10.1002/elsc.202200016.
The above article, published online on 13 September 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editors-in-Chief, Ralf Takors, An-Ping Zeng; and Wiley-VCH GmbH.
The partial raw data provided by the authors could not address the original concerns, showed inconsistencies with the published results, and ultimately raised additional doubts about the study's overall reliability. Consequently, the editors have lost confidence in the presented data and decided to retract the paper. The authors’ institute has been informed of the allegations and the decision to retract but remained unresponsive. The authors disagree with the retraction.
引用本文:E. Rahmani, M. Pourmadadi, S. a . Ghorbanian, F. Yazdian, H. Rashedi, M. Navaee,“ph响应壳聚糖-蒙脱石-氮掺杂碳量子点纳米载体的制备及其在肿瘤治疗中的应用”,生命科学工程,22,no。10 (2022): 634-649, https://doi.org/10.1002/elsc.202200016.The上述文章于2022年9月13日在线发表在Wiley online Library (wileyonlinelibrary.com)上,经主编Ralf Takors、曾安平;Wiley-VCH GmbH作者提供的部分原始数据无法解决最初的担忧,与已发表的结果不一致,最终引发了对该研究总体可靠性的额外质疑。因此,编辑们对所提供的数据失去了信心,决定撤回这篇论文。作者研究所已被告知这些指控和撤回决定,但仍未作出回应。作者不同意撤稿。
{"title":"RETRACTION: Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy","authors":"","doi":"10.1002/elsc.70033","DOIUrl":"10.1002/elsc.70033","url":null,"abstract":"<p><b>RETRACTION</b>: E. Rahmani, M. Pourmadadi, S. A. Ghorbanian, F. Yazdian, H. Rashedi, and M. Navaee, “Preparation of a pH-Responsive Chitosan-Montmorillonite-Nitrogen-Doped Carbon Quantum Dots Nanocarrier for Attenuating Doxorubicin Limitations in Cancer Therapy,” <i>Engineering in Life Sciences</i> 22, no. 10 (2022): 634–649, https://doi.org/10.1002/elsc.202200016.</p><p>The above article, published online on 13 September 2022 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editors-in-Chief, Ralf Takors, An-Ping Zeng; and Wiley-VCH GmbH.</p><p>The partial raw data provided by the authors could not address the original concerns, showed inconsistencies with the published results, and ultimately raised additional doubts about the study's overall reliability. Consequently, the editors have lost confidence in the presented data and decided to retract the paper. The authors’ institute has been informed of the allegations and the decision to retract but remained unresponsive. The authors disagree with the retraction.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"25 7","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/elsc.70033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144614971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lennart Jacobtorweihe, Sven Göbel, Markus Wolschek, Jennifer Altomonte, Udo Reichl, Yvonne Genzel
Oncolytic viruses as agents for the treatment of various types of cancer have demonstrated their potential in many clinical studies over the past decades. In particular, rVSV-NDV (a recombinant vesicular stomatitis virus [VSV] construct with fusogenic Newcastle disease virus glycoproteins) shows promising preclinical results. This is due to its safety profile, immunostimulatory effects, and efficacy based on strong syncytia formation. Since virotherapy requires a high input of infectious viruses, efficient production processes are needed. Good manufacturing practice (GMP)-compliant CCX.E10 cells have been previously reported as a high-titer-producing rVSV-NDV candidate in batch mode. Here, semi-perfusion was used to test quail-originated CCX.E10 cells for rVSV-NDV production at high cell densities and in different cell culture media. The best condition was transferred to a full perfusion process in a 3 L bioreactor using a tangential follow depth filtration (TFDF) device for cell retention. The integrated depth filter with a pore size of 2–5 µm allowed 99.9% cell retention at viable cell concentrations (VCCs) of up to 20.6 × 106 cells/mL and continuous virus harvesting. With this setup, we were able to produce 1.33 × 109 TCID50/mL infectious virus with a 5-fold increase in space-time yield (STY) compared to a batch process as a control.
Practical application: Despite significant progress in oncolytic virus development, early research primarily focuses on viral design and therapeutic potential, often overlooking production challenges until later stages. This gap hinders clinical translation, as manufacturing high oncolytic virus doses (up to 10¹¹ infectious particles per injection) remains a major bottleneck. Implementing GMP-compliant cell substrates alongside perfusion cultures is essential to overcoming the low yields of traditional batch production. These advancements have far-reaching implications for reducing costs, increasing dose availability, and accelerating the clinical adoption of this promising immunotherapy.
{"title":"High Cell Density Perfusion Process of Quail Cells Producing Oncolytic rVSV-NDV","authors":"Lennart Jacobtorweihe, Sven Göbel, Markus Wolschek, Jennifer Altomonte, Udo Reichl, Yvonne Genzel","doi":"10.1002/elsc.70035","DOIUrl":"10.1002/elsc.70035","url":null,"abstract":"<p>Oncolytic viruses as agents for the treatment of various types of cancer have demonstrated their potential in many clinical studies over the past decades. In particular, rVSV-NDV (a recombinant vesicular stomatitis virus [VSV] construct with fusogenic Newcastle disease virus glycoproteins) shows promising preclinical results. This is due to its safety profile, immunostimulatory effects, and efficacy based on strong syncytia formation. Since virotherapy requires a high input of infectious viruses, efficient production processes are needed. Good manufacturing practice (GMP)-compliant CCX.E10 cells have been previously reported as a high-titer-producing rVSV-NDV candidate in batch mode. Here, semi-perfusion was used to test quail-originated CCX.E10 cells for rVSV-NDV production at high cell densities and in different cell culture media. The best condition was transferred to a full perfusion process in a 3 L bioreactor using a tangential follow depth filtration (TFDF) device for cell retention. The integrated depth filter with a pore size of 2–5 µm allowed 99.9% cell retention at viable cell concentrations (VCCs) of up to 20.6 × 10<sup>6</sup> cells/mL and continuous virus harvesting. With this setup, we were able to produce 1.33 × 10<sup>9</sup> TCID<sub>50</sub>/mL infectious virus with a 5-fold increase in space-time yield (STY) compared to a batch process as a control.</p><p><i>Practical application:</i> Despite significant progress in oncolytic virus development, early research primarily focuses on viral design and therapeutic potential, often overlooking production challenges until later stages. This gap hinders clinical translation, as manufacturing high oncolytic virus doses (up to 10¹¹ infectious particles per injection) remains a major bottleneck. Implementing GMP-compliant cell substrates alongside perfusion cultures is essential to overcoming the low yields of traditional batch production. These advancements have far-reaching implications for reducing costs, increasing dose availability, and accelerating the clinical adoption of this promising immunotherapy.</p>","PeriodicalId":11678,"journal":{"name":"Engineering in Life Sciences","volume":"25 7","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/elsc.70035","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144614972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}